Aviva’s Oracle ORCL Stock Holding History

Aviva’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221M	Buy	1,509,274 +40,080	+3%	+$7.26M	0.33%	56
2026 Q1	$216M	Buy	1,469,194 +41,859	+3%	+$6.8M	0.36%	46
2025 Q4	$278M	Buy	1,427,335 +83,597	+6%	+$19.9M	0.47%	33
2025 Q3	$378M	Buy	1,343,738 +87,052	+7%	+$22.2M	0.69%	20
2025 Q2	$275M	Buy	1,256,686 +95,137	+8%	+$15.4M	0.57%	24
2025 Q1	$162M	Buy	1,161,549 +163,373	+16%	+$26.6M	0.39%	41
2024 Q4	$166M	Buy	998,176 +183,941	+23%	+$32.7M	0.43%	38
2024 Q3	$139M	Buy	814,235 +18,864	+2%	+$2.73M	0.36%	47
2024 Q2	$112M	Buy	795,371 +134,452	+20%	+$16.7M	0.31%	59
2024 Q1	$83M	Sell	660,919 -31,166	-5%	-$3.57M	0.27%	71
2023 Q4	$73M	Buy	692,085 +48,546	+8%	+$5.3M	0.26%	73
2023 Q3	$68.2M	Buy	643,539 +19,554	+3%	+$2.26M	0.29%	64
2023 Q2	$74.3M	Buy	623,985 +64,201	+11%	+$6.64M	0.3%	64
2023 Q1	$52M	Sell	559,784 -18,335	-3%	-$1.61M	0.24%	84
2022 Q4	$47.3M	Sell	578,119 -30,241	-5%	-$2.3M	0.23%	91
2022 Q3	$37.2M	Sell	608,360 -137,111	-18%	-$10M	0.21%	94
2022 Q2	$52.1M	Buy	745,471 +174,347	+31%	+$12.8M	0.28%	66
2022 Q1	$47.2M	Buy	571,124 +34,314	+6%	+$2.78M	0.24%	82
2021 Q4	$46.8M	Buy	536,810 +4,722	+0.9%	+$443K	0.2%	111
2021 Q3	$46.4M	Buy	532,088 +171,273	+47%	+$15.1M	0.21%	104
2021 Q2	$28.1M	Sell	360,815 -53,860	-13%	-$4.22M	0.12%	177
2021 Q1	$29.1M	Buy	414,675 +8,292	+2%	+$537K	0.14%	149
2020 Q4	$26.3M	Sell	406,383 -49,533	-11%	-$2.95M	0.14%	150
2020 Q3	$27.2M	Sell	455,916 -38,403	-8%	-$2.18M	0.16%	116
2020 Q2	$27.3M	Sell	494,319 -270,332	-35%	-$14.3M	0.17%	110
2020 Q1	$37M	Sell	764,651 -23,635	-3%	-$1.22M	0.27%	78
2019 Q4	$41.8M	Sell	788,286 -68,261	-8%	-$3.76M	0.25%	88
2019 Q3	$47.1M	Buy	856,547 +3,154	+0.4%	+$174K	0.32%	72
2019 Q2	$48.6M	Sell	853,393 -63,267	-7%	-$3.42M	0.33%	66
2019 Q1	$49.2M	Sell	916,660 -200,416	-18%	-$10.2M	0.33%	76
2018 Q4	$50.4M	Sell	1,117,076 -747,535	-40%	-$35.8M	0.38%	67
2018 Q3	$96.1M	Sell	1,864,611 -118,118	-6%	-$5.74M	0.53%	40
2018 Q2	$87.4M	Sell	1,982,729 -33,707	-2%	-$1.55M	0.52%	40
2018 Q1	$92.3M	Sell	2,016,436 -82,134	-4%	-$4.08M	0.56%	38
2017 Q4	$99.2M	Buy	2,098,570 +7,098	+0.3%	+$348K	0.56%	40
2017 Q3	$101M	Buy	2,091,472 +79,200	+4%	+$3.94M	0.54%	42
2017 Q2	$101M	Sell	2,012,272 -138,344	-6%	-$6.3M	0.56%	38
2017 Q1	$96M	Sell	2,150,616 -124,305	-5%	-$5.18M	0.55%	41
2016 Q4	$87.5M	Buy	2,274,921 +87,806	+4%	+$3.43M	0.52%	41
2016 Q3	$85.9M	Buy	2,187,115 +94,707	+5%	+$3.86M	0.54%	40
2016 Q2	$85.6M	Buy	2,092,408 +237,562	+13%	+$9.49M	0.59%	39
2016 Q1	$75.9M	Sell	1,854,846 -17,102	-0.9%	-$633K	0.56%	40
2015 Q4	$68.4M	Buy	1,871,948 +16,262	+0.9%	+$621K	0.52%	43
2015 Q3	$67M	Sell	1,855,686 -178,045	-9%	-$6.84M	0.56%	37
2015 Q2	$82M	Buy	2,033,731 +62,093	+3%	+$2.69M	0.58%	35
2015 Q1	$85.1M	Buy	1,971,638 +301,248	+18%	+$13.1M	0.58%	36
2014 Q4	$75.1M	Buy	1,670,390 +6,328	+0.4%	+$258K	0.58%	34
2014 Q3	$63.7M	Sell	1,664,062 -7,732	-0.5%	-$313K	0.5%	42
2014 Q2	$67.8M	Sell	1,671,794 -5,210	-0.3%	-$214K	0.52%	42
2014 Q1	$68.6M	Sell	1,677,004 -12,535	-0.7%	-$477K	0.56%	38
2013 Q4	$64.6M	Buy	1,689,539 +703	+0%	+$24.2K	0.54%	37
2013 Q3	$56M	Buy	1,688,836 +216,970	+15%	+$7.04M	0.49%	43
2013 Q2	$45.2M	Buy	+1,471,866	New	+$48.8M	0.46%	47

Other funds holding ORCL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Aviva's ORCL Position: Q2 2026 in Review

Aviva increased its Oracle (ORCL) stake by 2.7% in Q2 2026, buying an estimated $7.26M and bringing the position to 1,509,274 shares worth $221M. The position accounts for 0.33% of the portfolio, ranked #56.

Aviva first reported a position in ORCL in Q2 2013 and has held it in 53 quarters since. The position peaked at $378M in Q3 2025. 3,503 funds tracked by Wall St. Rank hold ORCL as of Q2 2026.

Aviva held 1,509,274 shares of Oracle worth $221M as of Q2 2026.
Aviva bought 40,080 Oracle shares in Q2 2026, an estimated $7.26M.
Oracle made up 0.33% of Aviva's portfolio in Q2 2026, its #56 holding.
Aviva first reported a position in Oracle in Q2 2013 and has held it in 53 quarters since.
Aviva's Oracle position peaked at $378M in Q3 2025.
3,503 funds tracked by Wall St. Rank held Oracle as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.